News | APMA
  • CMS will require all claims submitted on or after January 1, 2020, to use the Medicare Beneficiary Identifier (MBI), even for services provided before January 1, 2020. With a few exceptions, Medicare will reject claims submitted with Health Insurance Claim Numbers (HICNs) and all eligibility transactions you submit with HICNs.

  • Beginning January 1, 2020, anyone ordering advanced diagnostic imaging (MRI, CT, or nuclear studies) for a Medicare Part B outpatient must first consult Appropriate Use Criteria (AUC) using a Clinical Decision Support Mechanism (CDSM).

  • The APMA Center for Professional Advocacy (CPA) is delighted to announce that 10 state components will receive an Innovation Grant in 2020. These grants are designed to help state components with their scope-of-practice and physician definition advocacy efforts and their efforts to educate and build relationships with MD/DOs, policymakers, and payers.

  • APMA submitted on comments last week to CMS in response to its Request for Information on the Future of Program Integrity.

  • APMA Clinical Affairs Director Dyane Tower, DPM, MPH, MS, testified before the Massachusetts legislature’s Joint Committee on Public Health last week in support of legislation to modernize the podiatric scope-of-practice statute.

  • Want data that can help you negotiate a higher salary in your next job or benchmark your own performance? Register today for the upcoming lunch-and-learn webinar, “2020 MGMA Compensation Surveys—Are You Ready?” on December 12 at 2 p.m. ET.

  • The 19th Annual CAC-PIAC Meeting took place on Friday, November 15, in Alexandria, VA. The one-day event featured key industry speakers and provided attendees the opportunity to learn from each other while discussing local concerns. Check out a summary from APMA President David G. Edwards, DPM

  • APMA submitted comments to Wisconsin Physicians’ Services (WPS) on November 8 in response to its proposed Draft Wound Care Local Coverage Determination (LCD) DL37228. This draft LCD, as written, would continue to not provide coverage for debridement of Stage II pressure ulcers or chronic diabetic foot ulcers, unless neuropathy and/or neuroischemia were present, and chronic non-pressure ulcers with tissue severity of "Limited to Breakdown of Skin."

  • Blue Ribbon Panel on Special Areas of Practice and Certifying Boards: Update and Call for Comments
    October 28, 2019

    In support of a recommendation from the APMA Board of Trustees and Council on Podiatric Medical Education, the 2019 APMA House of Delegates approved a resolution calling for a Blue Ribbon Panel to review and study the history, traditions, and current circumstances associated with the recognition of special areas of practice and recognition of certifying boards.

  • If you are a member practicing in Indiana, Iowa, Kansas, Michigan, Missouri, or Nebraska, be on the lookout for an action alert from your state component!

  • View News Archives

APMA welcomes inquiries from the media! The Media Room provides journalists with information on podiatric medicine, educational campaigns, and national surveys related to podiatry and foot health. More information and fact sheets can also be found in our Patients & the Public section.

Please reach out to PR Specialist Kevin Hess (phone 301-581-9221) for questions or interview requests.

Today’s Podiatrist in the News

Subscribe to APMA Press Alerts


* indicates a required field